Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection
- PMID: 1332922
- DOI: 10.1002/hep.1840160611
Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection
Abstract
A total of 238 patients who received curative hepatic resections during the last 10 yr were observed to search for the risk factors linked to early tumor recurrence of human hepatocellular carcinoma after hepatectomy. The results revealed that tumor size, tumor appearance and DNA ploidy were the factors in predicting tumor recurrence after resection for hepatocellular carcinoma. Patients with a tumor size less than or equal to 5 cm or a tumor appearance of the solitary type had better disease-free survival than did those with a tumor size greater than 5 cm or a tumor appearance of multiple/daughter nodule types (p < 0.05). Although patients with pattern III (aneuploid with > or = 2 G0/G1 peaks) hepatoma had fewer statistically significant differences (p = 0.19) than did those with pattern I (diploid) or pattern II (aneuploid with single G0/G1 peak) tumors in predicting tumor recurrence, they did have poorer results in terms of the overall survival rate (p < 0.05). We conclude that patients with hepatocellular carcinoma having the aforementioned risk factors should be observed closely.
Similar articles
-
DNA ploidy study of resected hepatocellular carcinoma in cirrhotic liver.J Hepatol. 1996 Dec;25(6):854-8. doi: 10.1016/s0168-8278(96)80289-3. J Hepatol. 1996. PMID: 9007713
-
Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.Hepatogastroenterology. 2003 Nov-Dec;50(54):1991-5. Hepatogastroenterology. 2003. PMID: 14696450
-
Laparoscopic Versus Open Hepatic Resection for Solitary Hepatocellular Carcinoma Less Than 5 cm in Cirrhotic Patients: A Randomized Controlled Study.J Laparoendosc Adv Surg Tech A. 2018 Mar;28(3):302-310. doi: 10.1089/lap.2017.0518. Epub 2017 Nov 27. J Laparoendosc Adv Surg Tech A. 2018. PMID: 29172949 Clinical Trial.
-
Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma.Dig Liver Dis. 2016 Feb;48(2):189-96. doi: 10.1016/j.dld.2015.11.010. Epub 2015 Nov 23. Dig Liver Dis. 2016. PMID: 26675381
-
Liver resection for hepatocellular carcinoma in cirrhotic patients.Ital J Gastroenterol. 1992 Feb;24(2):105-10. Ital J Gastroenterol. 1992. PMID: 1315591 Review.
Cited by
-
Factors associated with disease survival after surgical resection in Chinese patients with hepatocellular carcinoma.World J Surg. 2006 Mar;30(3):439-45. doi: 10.1007/s00268-005-0608-6. World J Surg. 2006. PMID: 16479331
-
Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas.World J Surg. 2004 Aug;28(8):787-91. doi: 10.1007/s00268-004-7320-9. Epub 2004 Aug 3. World J Surg. 2004. PMID: 15457359
-
Hepatic arterial infusion chemotherapy for patients with huge unresectable hepatocellular carcinoma.PLoS One. 2014 May 13;9(5):e92784. doi: 10.1371/journal.pone.0092784. eCollection 2014. PLoS One. 2014. PMID: 24824520 Free PMC article.
-
Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease.J Gastrointest Surg. 2011 Aug;15(8):1450-8. doi: 10.1007/s11605-011-1540-8. Epub 2011 Apr 22. J Gastrointest Surg. 2011. PMID: 21512848
-
Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI Grade.J Gastrointest Surg. 2018 Jul;22(7):1230-1238. doi: 10.1007/s11605-018-3745-6. Epub 2018 May 7. J Gastrointest Surg. 2018. PMID: 29736665
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical